Antisense modulation of IL-1 receptor-associated kinase-4 expression
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Feb 17, 2004
Grant Date -
May 8, 2003
app pub date -
Sep 28, 2001
filing date -
Nov 25, 1998
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Antisense compounds, compositions and methods are provided for modulating the expression of IL-1 receptor-associated kinase-4. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding IL-1 receptor-associated kinase-4. Methods of using these compounds for modulation of IL-1 receptor-associated kinase-4 expression and for treatment of diseases associated with expression of IL-1 receptor-associated kinase-4 are provided.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully